DCM
CNMD icon

Defilade Capital Management’s CONMED CNMD Stock Holding History

Defilade Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-104,129
Closed -$4.23M – 35
2025
Q4 		$4.23M Buy
+104,129
New +$4.53M 0.57% 32

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Defilade Capital Management's CNMD Position: Q1 2026 in Review

Defilade Capital Management sold out of CONMED (CNMD) in Q1 2026, closing a stake of 104,129 shares — an estimated $4.23M sold.

Defilade Capital Management first reported a position in CNMD in Q4 2025 and held it in 1 quarter. The position peaked at $4.23M in Q4 2025. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Defilade Capital Management reported no remaining CONMED position as of Q1 2026 after selling out during the quarter.
  • Defilade Capital Management sold 104,129 CONMED shares in Q1 2026, an estimated $4.23M.
  • Defilade Capital Management first reported a position in CONMED in Q4 2025 and held it in 1 quarter.
  • Defilade Capital Management's CONMED position peaked at $4.23M in Q4 2025.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Defilade Capital Management's 13F filing for Q1 2026, filed 14 May 2026.